by
Mungus Mungus March 9, 2022
Apparent use seems to produce more opioid printing and tobacco addiction, end-of-life care problems, antidepressants, and PTSD. In October 2018, the US Food and Drug Administration approved the term “treatment success” for psilocybin for depression. In May 2019, in Denver, Colorado, vote...